Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Open in API
Filings indexed 2,231 across all filing types
Latest filing 2025-11-03 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1789

About SPT

https://www.scinopharm.com/tw

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
公告本公司董事會通過114年第三季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (1789 神隆) reporting the board's approval of the consolidated financial report for the third quarter of the year 114 (Taiwan calendar, corresponding to 2025). It includes cumulative financial data from January 1 to September 30, such as revenue, gross profit, operating profit, net profit, EPS, total assets, liabilities, and equity. The document is short (906 characters) and primarily serves as a notification of the board's approval of the quarterly financial report rather than the full report itself. It does not contain detailed financial statements or extensive analysis, but summary financial figures. This fits the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data. Therefore, the document should be classified as an Interim / Quarterly Report (IR).
2025-11-03 Chinese
公告本公司114年第三季合併財務報告董事會預計召開日期 為114年11月03日
Regulatory Filings Classification · 95% confidence The document is a short announcement (551 characters) from a company (1789 神隆) stating the date of the upcoming board meeting (114/11/03) where the third quarter consolidated financial report will be presented or approved. It does not contain the actual financial report or detailed financial data, but rather informs about the scheduling of the board meeting and the expected report to be discussed. This fits the pattern of a Regulatory Filing (RNS) as it is a general regulatory announcement about corporate events and reporting schedules, not the report itself or a detailed financial document.
2025-10-23 Chinese
114年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 神隆, providing information about fund loans and endorsement guarantees for the current and previous months. It contains tabular data with amounts and limits but is very short (608 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure related to financial guarantees and fund loans rather than a full report or announcement of a report. There is no indication of an annual or interim report, audit report, or other detailed filings. Given the nature and length, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-10-09 Chinese
114年9月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a revenue summary report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes compared to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document length is short (776 characters) and it primarily provides summarized financial data without detailed financial statements or management discussion. It is not an announcement of a report publication but a brief financial summary. This fits the definition of a Fund Information / Factsheet (FS), which is a brief summary of key company financials and market info.
2025-10-09 Chinese
114年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, chairman, general manager, and their related parties. It shows specific share counts, increases, decreases, and trust holdings. The content is focused on insider share transactions and holdings rather than financial results, governance policies, or meeting materials. There is no indication of it being a full financial report, earnings release, or management discussion. The document is not a brief announcement but a detailed insider shareholding report. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is substantial and contains actual data on insider shareholdings and changes, confirming it is a substantive insider dealing report rather than a mere announcement or certification.
2025-10-08 Chinese
114年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related information. It is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. The content matches the description of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. There is no indication that this is an announcement of a report or a certification. The document length is moderate and contains substantive data on insider holdings. Therefore, the appropriate classification is Director's Dealing (DIRS).
2025-10-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.